Inicia sesión Registrate Mi Biblioteca idioma

Idioma

biblioteca idioma abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará la selección de artículos sobre Trastornos del Movimiento clasificados según los 11 tipos establecidos por International Parkinson & Movement Disorder Society.

Corea y enfermedad de Huntington

262 ARTíCULOS , VIENDO DEL 61 AL 75

PUBMED

AAV5-miHTT Gene Therapy Demonstrates Sustained Huntingtin Lowering and Functional Improvement in Huntington Disease Mouse Models.

Spronck EA, Brouwers CC, Vallès A, de Haan M, Petry H, van Deventer SJ, Konstantinova P, Evers MM.

Mol Ther Methods Clin Dev. 2019 Mar 16;13:334-343. doi: 10.1016/j.omtm.2019.03.002. eCollection 2019 Jun 14.

0

0

0

PUBMED

Genetic deletion of S6k1 does not rescue the phenotypic deficits observed in the R6/2 mouse model of Huntington's disease.

Irvine EE, Katsouri L, Plattner F, Al-Qassab H, Al-Nackkash R, Bates GP, Withers DJ.

Sci Rep. 2019 Nov 6;9(1):16133. doi: 10.1038/s41598-019-52391-3.

0

0

0

PUBMED

A case-note review of continued pregnancies found to be at a high risk of Huntington's disease: considerations for clinical practice.

Wadrup F, Holden S, MacLeod R, Miedzybrodzka Z, Németh AH, Owens S, Pasalodos S, Quarrell O, Clarke AJ; UK Huntington’s Disease Predictive Testing Consortium..

Eur J Hum Genet. 2019 Mar 19. doi: 10.1038/s41431-019-0375-8. [Epub ahead of print]

0

0

0

PUBMED

End-of-life measures in Huntington disease: HDQLIFE Meaning and Purpose, Concern with Death and Dying, and End of Life Planning.

Carlozzi NE, Boileau NR, Paulsen JS, Perlmutter JS, Lai JS, Hahn EA, McCormack MK, Nance MA, Cella D, Barton SK, Downing NR.

J Neurol. 2019 Jun 12. doi: 10.1007/s00415-019-09417-7. [Epub ahead of print]

0

0

0

PUBMED

Sydenham's Chorea.

Risavi BL, Iszkula E, Yost B.

J Emerg Med. 2019 Apr 16. pii: S0736-4679(19)30099-X. doi: 10.1016/j.jemermed.2019.02.012. [Epub ahead of print]

0

0

0

PUBMED

Longitudinal study revealing motor, cognitive and behavioral decline in a transgenic minipig model of Huntington's disease.

Baxa M, Levinska B, Skrivankova M, Pokorny M, Juhasova J, Klima J, Klempir J, Motlı K J, Juhas S, Ellederova Z.

Dis Model Mech. 2019 Dec 12;13(2). pii: dmm041293. doi: 10.1242/dmm.041293.

0

0

0

PUBMED

Aberrant brain network connectivity in presymptomatic and manifest Huntington's disease: A systematic review.

Pini L, Jacquemot C, Cagnin A, Meneghello F, Semenza C, Mantini D, Vallesi A.

Hum Brain Mapp. 2020 Jan;41(1):256-269. doi: 10.1002/hbm.24790. Epub 2019 Sep 18. Review.

0

0

0

PUBMED

Sleep Disorders in Huntington's Disease.

Herzog-Krzywoszanska R, Krzywoszanski L.

Front Psychiatry. 2019 Apr 12;10:221. doi: 10.3389/fpsyt.2019.00221. eCollection 2019. Review.

0

0

0

PUBMED

Erucic acid, a nutritional PPARδ-ligand may influence Huntington's disease pathogenesis.

Altinoz MA, Ozpinar A, Ozpinar A, Hacker E.

Metab Brain Dis. 2020 Jan;35(1):1-9. doi: 10.1007/s11011-019-00500-6. Epub 2019 Oct 17. Review.

0

0

0

PUBMED

Genetic Counseling in Huntington's Disease: Potential New Challenges on Horizon?

Migliore S, Jankovic J, Squitieri F.

Front Neurol. 2019 Apr 30;10:453. doi: 10.3389/fneur.2019.00453. eCollection 2019.

0

0

0

PUBMED

Rationally designed small molecules targeting toxic CAG repeat RNA that causes Huntington's disease (HD) and spinocerebellar ataxia (SCAs).

Khan E, Biswas S, Mishra SK, Mishra R, Samanta S, Mishra A, Tawani A, Kumar A.

Biochimie. 2019 May 8;163:21-32. doi: 10.1016/j.biochi.2019.05.001. [Epub ahead of print]

0

0

0

PUBMED

Bim contributes to the progression of Huntington's disease-associated phenotypes.

Roberts SL, Evans T, Yang Y, Fu Y, Button RW, Sipthorpe RJ, Cowan K, Valionyte E, Anichtchik O, Li H, Lu B, Luo S.

Hum Mol Genet. 2019 Dec 9. pii: ddz275. doi: 10.1093/hmg/ddz275. [Epub ahead of print]

0

0

0

PUBMED

Targeting the neuronal calcium sensor DREAM with small-molecules for Huntington's disease treatment.

Lopez-Hurtado A, Peraza DA, Cercos P, Lagartera L, Gonzalez P, Dopazo XM, Herranz R, Gonzalez T, Martin-Martinez M, Mellström B, Naranjo JR, Valenzuela C, Gutierrez-Rodriguez M.

Sci Rep. 2019 May 13;9(1):7260. doi: 10.1038/s41598-019-43677-7.

0

0

0

PUBMED

Late-onset Huntington's disease with 40-42 CAG expansion.

Capiluppi E, Romano L, Rebora P, Nanetti L, Castaldo A, Gellera C, Mariotti C, Macerollo A, Cislaghi MG.

Neurol Sci. 2019 Dec 9. doi: 10.1007/s10072-019-04177-8. [Epub ahead of print]

0

0

0

PUBMED

Speech in prodromal and symptomatic Huntington's disease as a model of measuring onset and progression in dominantly inherited neurodegenerative diseases.

Chan JCS, Stout JC, Vogel AP.

Neurosci Biobehav Rev. 2019 Dec;107:450-460. doi: 10.1016/j.neubiorev.2019.08.009. Epub 2019 Aug 13. Review.

0

0

0

Comentarios

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo HONcode Logo WIS

En colaboración con:

Zambon Neuroacademy